218 related articles for article (PubMed ID: 31131448)
1. Long noncoding RNA LINC-PINT regulates laryngeal carcinoma cell stemness and chemoresistance through miR-425-5p/PTCH1/SHH axis.
Yuan Z; Xiu C; Liu D; Zhou G; Yang H; Pei R; Ding C; Cui X; Sun J; Song K
J Cell Physiol; 2019 Dec; 234(12):23111-23122. PubMed ID: 31131448
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA AFAP1-AS1/miR-320a/RBPJ axis regulates laryngeal carcinoma cell stemness and chemoresistance.
Yuan Z; Xiu C; Song K; Pei R; Miao S; Mao X; Sun J; Jia S
J Cell Mol Med; 2018 Sep; 22(9):4253-4262. PubMed ID: 29971915
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA LINC-PINT inhibits non-small cell lung cancer progression through sponging miR-218-5p/PDCD4.
Zhang L; Hu J; Li J; Yang Q; Hao M; Bu L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1595-1602. PubMed ID: 31010333
[TBL] [Abstract][Full Text] [Related]
4. LncRNA LINC-PINT increases SOCS1 expression by sponging miR-155-5p to inhibit the activation of ERK signaling pathway in rheumatoid arthritis synovial fibroblasts induced by TNF-α.
Wang J; Zhao Q
Int Immunopharmacol; 2020 Jul; 84():106497. PubMed ID: 32289665
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA LINC-PINT is inhibited in gastric cancer and predicts poor survival.
Feng H; Zhang J; Shi Y; Wang L; Zhang C; Wu L
J Cell Biochem; 2019 Jun; 120(6):9594-9600. PubMed ID: 30569513
[TBL] [Abstract][Full Text] [Related]
6. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
Hao T; Huang S; Han F
Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
[TBL] [Abstract][Full Text] [Related]
7. [LncRNA LINC-PINT regulating proliferation and apoptosis of osteosarcoma cells by targeting miR-524-5p].
Yang H; Cao C; Wang LJ
Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):325-330. PubMed ID: 32375449
[No Abstract] [Full Text] [Related]
8. LncRNA LINC-PINT Inhibits Malignant Behaviors of Laryngeal Squamous Cell Carcinoma Cells via Inhibiting ZEB1.
Yang X; Miao S; Mao X; Xiu C; Sun J; Pei R; Jia S
Pathol Oncol Res; 2021; 27():584466. PubMed ID: 34257531
[No Abstract] [Full Text] [Related]
9. LINC-PINT suppresses breast cancer cell proliferation and migration via MEIS2/PPP3CC/NF-κB pathway by sponging miR-576-5p.
Li D; Hu A
Am J Med Sci; 2024 Mar; 367(3):201-211. PubMed ID: 37660994
[TBL] [Abstract][Full Text] [Related]
10. LncRNA LINC-PINT Inhibits Cancer Cell Proliferation, Invasion, and Migration in Osteosarcoma by Downregulating miRNA-21.
Liu W
Cancer Biother Radiopharm; 2019 May; 34(4):258-263. PubMed ID: 31070482
[No Abstract] [Full Text] [Related]
11. Long noncoding RNA LINC-PINT retards the abnormal growth of airway smooth muscle cells via regulating the microRNA-26a-5p/PTEN axis in asthma.
Gao P; Ding Y; Yin B; Gu H
Int Immunopharmacol; 2021 Oct; 99():107997. PubMed ID: 34315115
[TBL] [Abstract][Full Text] [Related]
12. Linc-PINT acted as a tumor suppressor by sponging miR-543 and miR-576-5p in esophageal cancer.
Zhang L; Chen J; Wang L; Chen L; Du Z; Zhu L; Cui M; Zhang M; Song L
J Cell Biochem; 2019 Dec; 120(12):19345-19357. PubMed ID: 31464068
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of lncRNA LINC-PINT Participates in the Recurrence of Esophageal Squamous Cell Carcinoma Possibly by Interacting miRNA-21.
Rong H; Chen B; Ma K; Wei X; Peng J; Zhu J
Cancer Biother Radiopharm; 2021 Apr; 36(3):273-279. PubMed ID: 32401035
[No Abstract] [Full Text] [Related]
14. LINC-PINT Suppresses the Aggressiveness of Thyroid Cancer by Downregulating miR-767-5p to Induce TET2 Expression.
Jia M; Li Z; Pan M; Tao M; Wang J; Lu X
Mol Ther Nucleic Acids; 2020 Dec; 22():319-328. PubMed ID: 33230437
[TBL] [Abstract][Full Text] [Related]
15. Role of Long Non-Coding RNA (LncRNA) LINC-PINT Downregulation in Cardiomyopathy and Retinopathy Progression Among Patients with Type 2 Diabetes.
Zha T; Su F; Liu X; Yang C; Liu L
Med Sci Monit; 2019 Nov; 25():8509-8514. PubMed ID: 31711064
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of long noncoding RNA TUG1 contributes to the development of laryngocarcinoma by targeting miR-145-5p/ROCK1 axis.
Zhuang S; Liu F; Wu P
J Cell Biochem; 2019 Aug; 120(8):13392-13402. PubMed ID: 30916820
[TBL] [Abstract][Full Text] [Related]
17. LncRNA Linc-PINT inhibits miR-523-3p to hamper retinoblastoma progression by upregulating Dickkopf-1 (DKK1).
Zhou X; Wang Y; Li Q; Ma D; Nie A; Shen X
Biochem Biophys Res Commun; 2020 Sep; 530(1):47-53. PubMed ID: 32828314
[TBL] [Abstract][Full Text] [Related]
18. LINC-PINT alleviates lung cancer progression via sponging miR-543 and inducing PTEN.
Wang S; Jiang W; Zhang X; Lu Z; Geng Q; Wang W; Li N; Cai X
Cancer Med; 2020 Mar; 9(6):1999-2009. PubMed ID: 31981466
[TBL] [Abstract][Full Text] [Related]
19. DGCR5 promotes cancer stem cell-like properties of radioresistant laryngeal carcinoma cells by sponging miR-506 via Wnt pathway.
Tang T; Shan G
J Cell Physiol; 2019 Aug; 234(10):18423-18431. PubMed ID: 30980388
[TBL] [Abstract][Full Text] [Related]
20. Small Nucleolar RNA Host Gene 12 (SNHG12) Promotes Proliferation and Invasion of Laryngeal Cancer Cells via Sponging miR-129-5p and Potentiating WW Domain-Containing E3 Ubiquitin Protein Ligase 1 (WWP1) Expression.
Li J; Sun S; Chen W; Yuan K
Med Sci Monit; 2019 Jul; 25():5552-5560. PubMed ID: 31348766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]